siRNA therapy lowers triglycerides in patients with unusual ailment

.RESEARCH EMPHASIZE.19 September 2024.

Plozasiran decreased triglyceride amounts through 80% and decreased the danger of pancreatitis in individuals along with consistent chylomicronemia, along with or without a hereditary prognosis.